# N-acetyl Cysteine in Post-reperfusion Pulmonary Injury in Chronic Thromboembolic Pulmonary Hypertension.

> **NCT04081012** · NA · UNKNOWN · sponsor: **Instituto Nacional de Cardiologia Ignacio Chavez** · enrollment: 34 (estimated)

## Conditions studied

- Chronic Thromboembolic Pulmonary Hypertension

## Interventions

- **DRUG:** N-acetyl cysteine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04081012
- **Lead sponsor:** Instituto Nacional de Cardiologia Ignacio Chavez
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-05-21
- **Primary completion:** 2023-05-21
- **Final completion:** 2023-05-21
- **Target enrollment:** 34 (ESTIMATED)
- **Last updated:** 2020-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04081012

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04081012, "N-acetyl Cysteine in Post-reperfusion Pulmonary Injury in Chronic Thromboembolic Pulmonary Hypertension.". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04081012. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*